CLINICAL AND RADIOGRAPHIC VARIABLES ASSOCIATED WITH MEDICATION-RELATED OSTEONECROSIS OF THE JAW (MRONJ) IN PATIENTS WITH MULTIPLE MYELOMA—A RETROSPECTIVE STUDY

Medication-related osteonecrosis of the jaws (MRONJ), which causes exposed bone in the maxillofacial region, persisted for 8 weeks in a patient who was receiving a bone-modulating agent.1 Multiple myeloma (MM) is a hematologic cancer that can cause bone disease. Therefore, a potent bisphosphonate is used to control bone metastasis, but one of its adverse effects is MRONJ. Previous studies that investigated risk factors associated with MRONJ were done in patients with different hematologic conditions, where the underlining condition might affect the result.

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://www.oooojournal.net/article/S2212-4403(18)31113-1/fulltext?rss=yes